English | Español
Patient Daily | Mar 30, 2026

Sanofi announces partnership with Kali Therapeutics in $1 billion immunology deal
Patient Daily | Mar 30, 2026

Pfizer expresses confidence in Lyme vaccine after mixed Phase 3 trial results
Patient Daily | Mar 30, 2026

Oryon announces $42 million funding for Parkinson’s cell therapy development
Patient Daily | Mar 30, 2026

FDA warns of seizure risk linked to Parkinson’s drugs with levodopa and carbidopa
Patient Daily | Mar 30, 2026

Earendil Labs secures $787 million for AI-driven biologics development
Patient Daily | Mar 30, 2026

Kevin Tang appointed CEO as Aurinia Pharmaceuticals restructures leadership team
Patient Daily | Mar 30, 2026

Gene therapies for hearing loss show promise despite recent setbacks in the field
Patient Daily | Mar 30, 2026

FDA’s new priority voucher program faces questions over transparency and selection process

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2026

FDA seen as more flexible under acting commissioner Kyle Diamantas
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study
+ Pharmaceuticals
Patient Daily | Jun 17, 2026

PwC reports strong biopharma M&A activity as sector shifts to precision science